Health Care & Life Sciences » Pharmaceuticals | Prestige Brands Holdings Inc.

Prestige Brands Holdings Inc. | Mutual Funds

Mutual Funds that own Prestige Brands Holdings Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Fidelity Small Cap Discovery Fund
3,000,000
5.8%
0
2.43%
04/30/2018
Undiscovered Managers Behavioral Value Fund
1,653,271
3.2%
-19,400
0.97%
07/31/2018
iShares Core S&P Mid Cap ETF
1,457,076
2.82%
1,176
0.11%
09/06/2018
JPMorgan Small Cap Equity Fund
1,435,259
2.77%
0
0.77%
07/31/2018
Vanguard Total Stock Market Index Fund
1,352,832
2.62%
1,610
0.01%
07/31/2018
Vanguard Small Cap Index Fund
1,334,844
2.58%
17,308
0.05%
07/31/2018
iShares Russell 2000 ETF
1,117,188
2.16%
-597
0.09%
09/06/2018
Fidelity Series Small Cap Discovery Fund
1,000,000
1.93%
0
2.12%
04/30/2018
Vanguard Small Cap Value Index Fund
840,270
1.62%
8,438
0.1%
07/31/2018
Janus Venture Fund
793,996
1.54%
69,800
0.83%
06/30/2018

About Prestige Brands Holdings

View Profile
Address
660 White Plains Road
Tarrytown New York 10591
United States
Employees -
Website http://www.prestigebrands.com
Updated 07/08/2019
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the following segments: North American Over-the-Counter (OTC) Healthcare, International OTC Healthcare, and Household Cleaning. The North American and International OTC Healthcare segments manages the following brands: BC/Goody's, Beano, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fess, Fleet, Gaviscon, Hydralyte, Luden's, Monistat, Nix, Pedia-Lax, and Summer's Eve.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.